(PharmaNewsWire.Com, October 26, 2019 ) The Chromatography Resin Market in drug discovery is estimated to grow from USD 273 million in 2016 to USD 401 million by 2022, at a compound annual growth rate (CAGR) of 6.7% during the forecast period. The growing use of chromatography resin in the food & beverage industry and the increased R&D in the biopharmaceutical industry are the market drivers.
Natural polymers are the largest type of chromatography resin.
The largest type of chromatography resin is natural polymer due to its hydrophilic properties and low solid density. Although natural polymer has lower mechanical stability than synthetic polymer, the former is used widely in industrial-scale purification of biomolecules. Agarose, dextran, and cellulose are extensively used natural polymers in different chromatography applications.
Affinity chromatography is the fastest-growing technique for chromatography resin.
The affinity chromatography segment is projected to register the highest CAGR during the forecast period due to the growing demand for therapeutic monoclonal antibodies, especially in the APAC region. The multi-modal chromatography segment is the second-fastest-growing technique because of its wide application in the purification of mammalian antibodies and recombinant proteins.
Browse in-depth TOC on "Chromatography Resin Market” 94 - Market Data Tables 41 - Figures 145 - Pages
The North American region accounted for the largest share of the overall market in 2016.
The chromatography resin market in drug discovery has been segmented based on region, into North America, Europe, Asia Pacific, and RoW. North America was the largest market in 2016. The growth of the monoclonal antibody therapeutics market and the biopharmaceutical industry has fueled the demand in the region.
The US is the leading market in the region and shows further growth potential. The consumption of chromatography resin is increasing in the country as the separation technology is being adopted in drug manufacturing and food processing.
The major market players are General Electric Company (US), Merck KGaA (Germany), Bio-Rad Laboratories Inc. (US), Pall Corporation (US), Thermo Fisher Scientific Inc. (US), and Tosoh Corporation (Japan). These companies have undertaken various strategies such as new product launch, expansion, and contract & agreement to increase their product offerings, customer base, and market presence.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: